Advertisement
Chinese drug firm CanSino hoping Brazil will approve Covid-19 vaccine after deal with local company
- Brazilian firm Biomm has signed an exclusive deal to market and distribute the Chinese company’s product in the country
- The drug has not yet been approved for emergency use by the WHO and it is unclear if the Brazilian authorities will give it the go-ahead
Reading Time:2 minutes
Why you can trust SCMP
China’s CanSino hopes to start distributing its Covid-19 vaccine in Brazil after signing a deal with a local company, although the country’s government has turned away from another widely used Chinese vaccine.
Advertisement
Biomm, a listed Brazilian biopharm company, announced on Friday that it had signed an exclusive deal to distribute and manufacture CanSino’s Covid-19 vaccine in Brazil.
It also said it will apply for an emergency use licence.
CanSino has not yet obtained emergency use approval from the World Health Organization, which has given the green light to two other Chinese vaccines by Sinopharm and Sinovac.
“We are pleased to be able to collaborate with a leading industrial partner that allows our Convidecia vaccine for COVID-19 to be a potential part of the fight against the pandemic in Brazil,” CanSino chief executive Yu Xuefeng said in a statement published on Biomm’s website.
“We look forward to moving forward and helping build mass immunisation in a timely manner.”
Advertisement